643
Views
76
CrossRef citations to date
0
Altmetric
Mini Review

Are Proteinases the Reason for Keratoconus?

, &
Pages 185-191 | Received 25 May 2009, Accepted 08 Nov 2009, Published online: 07 Apr 2010

REFERENCES

  • Rabinowitz YS. Keratoconus. Surv Ophthalmol. 1998;42:297–319.
  • Dastjerdi MH, Hashemi H. A quantitative corneal topography index for detection of keratoconus. J Refract Surg. 1998;14:427–436.
  • Suzuki M, Amano S, Honda N, et al. Longitudinal changes in corneal irregular astigmatism and visual acuity in eyes with keratoconus. Jpn J Ophthalmol. 2007;51:265–269.
  • Lema I, Duran JA. Inflammatory molecules in the tears of patients with keratoconus. Ophthalmology. 2005;112:654–659.
  • Lema I, Sobrino T, Duran JA, et al. Subclinical keratoconus and inflammatory molecules from tears. Br J Ophthalmol. 2009;93:820–824.
  • Jacq PL, Sale Y, Cochener B, et al. Keratoconus, changes in corneal topography and allergy. Study of 3 groups of patients. J Fr Ophtalmol. 1997;20:97–102.
  • Gasset AR, Houde WL, Garcia-Bengochea M. Hard contact lens wear as an environmental risk in keratoconus. Am J Ophthalmol. 1978;85:339–341.
  • Bawazeer AM, Hodge WG, Lorimer B. Atopy and keratoconus: A multivariate analysis. Br J Ophthalmol. 2000;84:834–836.
  • Cullen JF, Butler HG. Mongolism (Down’s syndrome) and keratoconus. Br J Ophthalmol. 1963;47:321–330.
  • Pearson AR, Soneji B, Sarvananthan N, et al. Does ethnic origin influence the incidence or severity of keratoconus? Eye. 2000;14 (Pt 4):625–628.
  • Georgiou T, Funnell CL, Cassels-Brown A, et al. Influence of ethnic origin on the incidence of keratoconus and associated atopic disease in Asians and white patients. Eye. 2004;18:379–383.
  • Heverly VL, Lowther G,. Epidemiology of keratoconus. Retrieved from <http://wwwoptindianaedu/lowther/html/keratoconus_epidemiology.htm> Last accessed 18 July 2009.
  • Fink BA, Wagner H, Steger-May K, et al. Differences in keratoconus as a function of gender. Am J Ophthalmol. 2005;140:459–468.
  • Ertan A, Muftuoglu O. Keratoconus clinical findings according to different age and gender groups. Cornea. 2008;27:1109–1113.
  • Krachmer JH, Feder RS, Belin MW. Keratoconus and related noninflammatory corneal thinning disorders. Surv Ophthalmol. 1984;28:293–322.
  • Bron AJ. Keratoconus. Cornea. 1988;7:163–169.
  • Cristina Kenney M, Brown DJ. The cascade hypothesis of keratoconus. Cont Lens Anterior Eye. 2003;26:139–146.
  • Collier SA. Is the corneal degradation in keratoconus caused by matrix-metalloproteinases? Clin Experiment Ophthalmol. 2001;29:340–344.
  • Critchfield JW, Calandra AJ, Nesburn AB, et al. Keratoconus: I. Biochemical studies. Exp Eye Res. 1988;46:953–963.
  • Nagase H, Woessner JF, Jr. Matrix metalloproteinases. J Biol Chem. 1999;274:21491–21494.
  • Harper E, Bloch KJ, Gross J. The zymogen of tadpole collagenase. Biochemistry. 1971;10:3035–3041.
  • Murphy G, Stanton H, Cowell S, et al. Mechanisms for pro matrix metalloproteinase activation. APMIS. 1999;107:38–44.
  • Murphy GJ, Murphy G, Reynolds JJ. The origin of matrix metalloproteinases and their familial relationships. FEBS Lett. 1991;289:4–7.
  • Hanemaaijer R, Visser H, Koolwijk P, et al. Inhibition of MMP synthesis by doxycycline and chemically modified tetracyclines (CMTs) in human endothelial cells. Adv Dent Res. 1998;12:114–118.
  • Fini ME, Cook JR, Mohan R. Proteolytic mechanisms in corneal ulceration and repair. Arch Dermatol Res. 1998;290:S12–S23.
  • Bode W, Fernandez-Catalan C, Grams F, et al. Insights into MMP-TIMP interactions. Ann N Y Acad Sci. 1999;878:73–91.
  • Murphy G, Nagase H. Progress in matrix metalloproteinase research. Mol Aspects Med. 2008;29:290–308.
  • Nagase H, Visse R, Murphy G. Structure and function of matrix metalloproteinases and TIMPs. Cardiovasc Res. 2006;69:562–573.
  • Woessner JF, Jr. MMPs and TIMPs—An historical perspective. Mol Biotechnol. 2002;22:33–49.
  • Kao WW, Vergnes JP, Ebert J, et al. Increased collagenase and gelatinase activities in keratoconus. Biochem Biophys Res Commun. 1982;107:929–936.
  • Rehany U, Lahav M, Shoshan S. Collagenolytic activity in keratoconus. Ann Ophthalmol. 1982;14:751–754.
  • Kenney MC, Chwa M, Escobar M, et al. Altered gelatinolytic activity by keratoconus corneal cells. Biochem Biophys Res Commun. 1989;161:353–357.
  • Fini ME, Yue BY, Sugar J. Collagenolytic/gelatinolytic metalloproteinases in normal and keratoconus corneas. Curr Eye Res. 1992;11:849–862.
  • Zhou L, Sawaguchi S, Twining SS, et al. Expression of degradative enzymes and protease inhibitors in corneas with keratoconus. Invest Ophthalmol Vis Sci. 1998;39:1117–1124.
  • Kenney MC, Chwa M, Opbroek AJ, et al. Increased gelatinolytic activity in keratoconus keratocyte cultures. A correlation to an altered matrix metalloproteinase-2/tissue inhibitor of metalloproteinase ratio. Cornea. 1994;13:114–124.
  • Smith VA, Matthews FJ, Majid MA, et al. Keratoconus: Matrix metalloproteinase-2 activation and TIMP modulation. Biochim Biophys Acta. 2006;1762:431–439.
  • Kenney MC, Chwa M, Alba A, et al. Localization of TIMP-1, TIMP-2, TIMP-3, gelatinase A and gelatinase B in pathological human corneas. Curr Eye Res. 1998;17:238–246.
  • Matthews FJ, Cook SD, Majid MA, et al. Changes in the balance of the tissue inhibitor of matrix metalloproteinases (TIMPs)-1 and -3 may promote keratocyte apoptosis in keratoconus. Exp Eye Res. 2007;84:1125–1134.
  • Kim WJ, Rabinowitz YS, Meisler DM, et al. Keratocyte apoptosis associated with keratoconus. Exp Eye Res. 1999;69:475–481.
  • Kaldawy RM, Wagner J, Ching S, et al. Evidence of apoptotic cell death in keratoconus. Cornea. 2002;21:206–209.
  • Alexander CM, Werb Z. Proteinases and extracellular matrix remodeling. Curr Opin Cell Biol. 1989;1:974–982.
  • Collier SA, Madigan MC, Penfold PL. Expression of membrane-type 1 matrix metalloproteinase (MT1-MMP) and MMP-2 in normal and keratoconus corneas. Curr Eye Res. 2000;21:662–668.
  • Murphy G, Willenbrock F, Crabbe T, et al. Regulation of matrix metalloproteinase activity. Ann N Y Acad Sci. 1994;732:31–41.
  • Sato H, Takino T, Okada Y, et al. A matrix metalloproteinase expressed on the surface of invasive tumour cells. Nature. 1994;370:61–65.
  • Stronglin AY, Collier Y, Bannikov G, et al. Mechanism of cell surface activation of 72-kDa type IV collagenase. J Biol Chem. 1995;270:5331–5338.
  • Ohuchi E, Imai K, Fujii Y, et al. Membrane type 1 matrix metalloproteinase digests interstitial collagens and other extracellular matrix macromolecules. J Biol Chem. 1997;272:2446–2451.
  • Heusel JW, Hanson RD, Silverman GA, et al. Structure and expression of a cluster of human hematopoietic serine protease genes found on chromosome 14q11.2. J Biol Chem. 1991;266:6152–6158.
  • Chwieralski CE, Welte T, Buhling F. Cathepsin-regulated apoptosis. Apoptosis. 2006;11:143–149.
  • Elliot S, Catanuto P, Marin-Castano ME, et al. RPE express MT1-MMP and its levels are regulated by estrogen and oxidant injury. Invest Ophthalmol Vis Sci. 2003;44:E-Abstract 478.
  • Grandas OH, Mountain DJ, Kirkpatrick SS, et al. Effect of hormones on matrix metalloproteinases gene regulation in human aortic smooth muscle cells. J Surg Res. 2008;148:94–99.
  • Spoerl E, Zubaty V, Raiskup-Wolf F, et al. Oestrogen-induced changes in biomechanics in the cornea as a possible reason for keratectasia. Br J Ophthalmol. 2007;91:1547–1550.
  • Suzuki T, Sullivan DA. Estrogen stimulation of proinflammatory cytokine and matrix metalloproteinase gene expression in human corneal epithelial cells. Cornea. 2005;24:1004–1009.
  • Skrzydlewska E, Sulkowska M, Koda M, et al. Proteolytic-antiproteolytic balance and its regulation in carcinogenesis. World J Gastroenterol. 2005;11:1251–1266.
  • Turk B, Turk D, Turk V. Lysosomal cysteine proteases: More than scavengers. Biochim Biophys Acta. 2000;1477:98–111.
  • Mohamed MM, Sloane BF. Cysteine cathepsins: Multifunctional enzymes in cancer. Nat Rev Cancer. 2006;6:764–775.
  • Whitelock RB, Fukuchi T, Zhou L, et al. Cathepsin G, acid phosphatase, and alpha 1-proteinase inhibitor messenger RNA levels in keratoconus corneas. Invest Ophthalmol Vis Sci. 1997;38:529–534.
  • Haeckel C, Krueger S, Buehling F, et al. Expression of cathepsin K in the human embryo and fetus. Dev Dyn. 1999;216:89–95.
  • Mackiewicz Z, Maatta M, Stenman M, et al. Collagenolytic proteinases in keratoconus. Cornea. 2006;25:603–610.
  • Chwa M, Atilano SR, Hertzog D, et al. Hypersensitive response to oxidative stress in keratoconus corneal fibroblasts. Invest Ophthalmol Vis Sci. 2008;49:4361–4369.
  • Im E, Kazlauskas A. The role of cathepsins in ocular physiology and pathology. Exp Eye Res. 2007;84:383–388.
  • Neurath H, Walsh KA. Role of proteolytic enzymes in biological regulation (a review). Proc Natl Acad Sci U S A. 1976;73:3825–3832.
  • Berquin IM, Sloane BF. Cathepsin B expression in human tumors. Adv Exp Med Biol. 1996;389:281–294.
  • Whitelock RB, Li Y, Zhou LL, et al. Expression of transcription factors in keratoconus, a cornea-thinning disease. Biochem Biophys Res Commun. 1997;235:253–258.
  • Wilson SE, He YG, Weng J, et al. Epithelial injury induces keratocyte apoptosis: Hypothesized role for the interleukin-1 system in the modulation of corneal tissue organization and wound healing. Exp Eye Res 1996;62:325–327.
  • Fabre EJ, Bureau J, Pouliquen Y, et al. Binding sites for human interleukin 1 alpha, gamma interferon and tumor necrosis factor on cultured fibroblasts of normal cornea and keratoconus. Curr Eye Res. 1991;10:585–592.
  • Zhou L, Whitelock RB, Yue BYJT, et al. Cytokine and receptor expression in keratoconus corneas. Invest Ophthalmol Vis Sci. 1996;37:S1017.
  • Kim SH, Mok JW, Kim HS, et al. Association of -31T>C and -511 C>T polymorphisms in the interleukin 1 beta (IL1B) promoter in Korean keratoconus patients. Mol Vis. 2008;14:2109–2116.
  • Cox SW, Eley BM, Kiili M, et al. Collagen degradation by interleukin-1beta-stimulated gingival fibroblasts is accompanied by release and activation of multiple matrix metalloproteinases and cysteine proteinases. Oral Dis. 2006;12:34–40.
  • Xue ML, Wakefield D, Willcox MD, et al. Regulation of MMPs and TIMPs by IL-1beta during corneal ulceration and infection. Invest Ophthalmol Vis Sci. 2003;44:2020–2025.
  • Li DQ, Lokeshwar BL, Solomon A, et al. Regulation of MMP-9 production by human corneal epithelial cells. Exp Eye Res. 2001;73:449–459.
  • Kim HS, Shang T, Chen Z, et al. TGF-beta1 stimulates production of gelatinase (MMP-9), collagenases (MMP-1, -13) and stromelysins (MMP-3, -10, -11) by human corneal epithelial cells. Exp Eye Res. 2004;79:263–274.
  • Zhou L, Yue BY, Twining SS, et al. Expression of wound healing and stress-related proteins in keratoconus corneas. Curr Eye Res. 1996;15:1124–1131.
  • Maier P, Broszinski A, Heizmann U, et al. Active transforming growth factor-beta2 is increased in the aqueous humor of keratoconus patients. Mol Vis. 2007;13:1198–1202.
  • Saghizadeh M, Brown DJ, Castellon R, et al. Overexpression of matrix metalloproteinase-10 and matrix metalloproteinase-3 in human diabetic corneas: A possible mechanism of basement membrane and integrin alterations. Am J Pathol. 2001;158:723–734.
  • Seppala HP, Maatta M, Rautia M, et al. EMMPRIN and MMP-1 in keratoconus. Cornea. 2006;25:325–330.
  • Caroline P, Andre M, Kinoshita B, et al. Etiology, diagnosis, and management of keratoconus: New thoughts and new understandings. Retrieved from <http://www.opt.pacificu.edu/ce/catalog/15167-AS/Keratoconus.html>. Last accessed 15 April 2009.
  • Nottingham J. Practical Observations on Conical Cornea: And on the Short Sight, and Other Defects of Vision Connected with It. London: J. Churchill, 1854.
  • Parker J, Ko WW, Pavlopoulos G, et al. Videokeratography of keratoconus in monozygotic twins. J Refract Surg. 1996;12:180–183.
  • Francois J. Heredity in Ophthalmology. St. Louis: CV Mosby, 1961.
  • Bisceglia L, De Bonis P, Pizzicoli C, et al. Linkage analysis in keratoconus: Replication of locus 5q21.2 and identification of other suggestive loci. Invest Ophthalmol Vis Sci. 2009;50:1081–1086.
  • Wang Y, Rabinowitz YS, Rotter JI, et al. Genetic epidemiological study of keratoconus: Evidence for major gene determination. Am J Med Genet. 2000;93:403–409.
  • Edwards M, McGhee CN, Dean S. The genetics of keratoconus. Clin Experiment Ophthalmol. 2001;29:345–351.
  • Shoji J, Kawaguchi A, Gotoh A, et al. Concentration of soluble interleukin-6 receptors in tears of allergic conjunctival disease patients. Jpn J Ophthalmol. 2007;51:332–337.
  • Leonardi A, Brun P, Abatangelo G, et al. Tear levels and activity of matrix metalloproteinase (MMP)-1 and MMP-9 in vernal keratoconjunctivitis. Invest Ophthalmol Vis Sci. 2003;44:3052–3058.
  • Maatta M, Kari O, Tervahartiala T, et al. Elevated expression and activation of matrix metalloproteinase 8 in tear fluid in atopic blepharoconjunctivitis. Cornea. 2008;27:297–301.
  • Schultz CL, Kunert KS. Interleukin-6 levels in tears of contact lens wearers. J Interferon Cytokine Res. 2000;20:309–310.
  • Bureau J, Fabre EJ, Hecquet C, et al. Modification of prostaglandin E2 and collagen synthesis in keratoconus fibroblasts, associated with an increase of interleukin 1 alpha receptor number. C R Acad Sci III. 1993;316:425–430.
  • Kamolmatyakul S, Chen W, Yang S, et al. IL-1alpha stimulates cathepsin K expression in osteoclasts via the tyrosine kinase-NF-kappaB pathway. J Dent Res. 2004;83:791–796.
  • Meijers MHM, Aisa CM, Billingham MEJ, et al. The effect of interleukin-1β and transforming growth factor β on cathepsin B activity in human articular chondrocytes. Inflammation Res. 1994;41:C198–C200.
  • Wollensak G, Spoerl E, Seiler T. Riboflavin/ultraviolet-a-induced collagen crosslinking for the treatment of keratoconus. Am J Ophthalmol. 2003;135:620–627.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.